Organon's VTAMA Data and Women's Health Grants Amidst Share Price Struggles

Organon presented new post-hoc analysis of VTAMA cream for atopic dermatitis, highlighting early and consistent benefits in adult and pediatric patients. The company also advanced its Asia Pacific Her Health Grant program, directing funding toward projects that expand access to women's health services across the region. These updates underscore Organon's focus on dermatology and women's health, despite a weak share price backdrop.